Merritt Healthcare announces $10.2 million Mount Sinai joint venture ASC deal

Merritt Healthcare is pleased to announce a $10.2 million joint venture with Mount Sinai Ambulatory Ventures, Inc., a wholly owned subsidiary of Mount Sinai Health System, to develop a single-specialty gastroenterology ambulatory surgery center in New York. Mount Sinai engaged Merritt Healthcare to develop and manage the new facility, which will operate out of existing leased space on the Upper West Side of Manhattan. The project’s certificate of need application is currently under consideration with the New York State Department of Health.

Mount Sinai Ambulatory Ventures, Inc., is strategically invested in a wide variety of enterprises, including ambulatory surgery centers, urgent care centers, management service organizations and health technology companies. Merritt Healthcare is the industry leader in the development, management and advisory of ambulatory surgery centers nationwide.

Leave a comment

© 2021 Merritt Healthcare Advisors. All Rights Reserved.

*Principals of Merritt Healthcare (“Merritt”) acted in their capacity as registered representatives of Burch & Company, Inc. (“BCI”), 4151 N. Mulberry Dr., Ste. 235, Kansas City, MO 64116, member FINRA/SIPC. Merritt principals are licensed investment banking agents of BCI. All services requiring a securities license are performed through BCI. BCI & Merritt are unaffiliated entities.